Weifeng Yu
机构:South China Agricultural University, Qingdao University, Fujian Medical University, Nanchang University, East China University of Science and Technology, Qingdao Agricultural University, China Pharmaceutical University, Second Military Medical University, Shanghai Jiao Tong University, Kunming Medical University, Wenzhou Medical University, Renji Hospital, First Affiliated Hospital of Wenzhou Medical University, Integrated Chinese Medicine (China), First Affiliated Hospital of Kunming Medical University, Eastern Hepatobiliary Surgery Hospital, Baoji City Central Hospital, State Key Laboratory of Chemical Engineering, Shenzhen Pingle Orthopedic Hospital, First Affiliated Hospital of Nanchang University, University of Virginia, Nanjing Medical University · ORCID:0000-0003-1979-6304
发表论文 382 篇 · 总被引 8188 次 · h-index 45
代表论文
- Semaglultide targets Spp1+ microglia/macrophage to attenuate neuroinflammation following perioperative stroke (2025 · Journal of Neuroinflammation · 被引 14)
- St3gal5-mediated sialylation of glyco-CD177 on neutrophils restricts neuroinflammation following CNS injury (2025 · Proceedings of the National Academy of Sciences · 被引 10)
- Cancer and neurotransmitter receptors (2025 · Chinese Medical Journal · 被引 8)
- Chinese clinical practice guidelines for total intravenous anaesthesia: a systematic review and expert consensus-based recommendations☆ (2025 · British Journal of Anaesthesia · 被引 5)
- κ-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice (2025 · British Journal of Anaesthesia · 被引 5)
- Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial (2025 · Cell Discovery · 被引 4)